ANN ARBOR STAGE IB HODGKIN LYMPHOMA

Clinical trials for ANN ARBOR STAGE IB HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new ANN ARBOR STAGE IB HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for ANN ARBOR STAGE IB HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for seniors with hodgkin lymphoma: Chemo-Free combo shows promise

Disease control Ongoing

This study tests a combination of two drugs, nivolumab and brentuximab vedotin, in people aged 60 and older (or younger people who cannot take standard chemotherapy) with untreated Hodgkin lymphoma. The goal is to see how well these drugs control the cancer by helping the immune …

Matched conditions: ANN ARBOR STAGE IB HODGKIN LYMPHOMA

Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control

Last updated Apr 29, 2026 07:13 UTC

ANN ARBOR STAGE IB HODGKIN LYMPHOMA

Get alerted when new ANN ARBOR STAGE IB HODGKIN LYMPHOMA trials appear

New hope for seniors with hodgkin lymphoma: Chemo-Free combo shows promise